Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

Bradley J. Monk, Michael W. Sill, Parviz Hanjani, Robert Edwards, Jacob Rotmensch, Koen De Geest, Albert J. Bonebrake, Joan L. Walker

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences